NeoDx

Call Directions Website Contact the business

NeoDx A Bengaluru-based startup that designs, develops, and manufactures IVD kits for Infectious Diseases, Oncology Treatment, and Genetic Disorders.

Some chemo side effects aren’t bad luck. They’re written in your DNA. 🧬For certain patients, a standard dose of fluoropy...
09/10/2026

Some chemo side effects aren’t bad luck. They’re written in your DNA. 🧬

For certain patients, a standard dose of fluoropyrimidine chemotherapy can turn toxic, even fatal. A genetic test can flag that risk before the first dose.

On October 27, NeoDx is hosting a live webinar: 𝑬𝒍𝒊𝒎𝒊𝒏𝒂𝒕𝒊𝒏𝒈 𝑫𝒆𝒂𝒕𝒉 𝒇𝒓𝒐𝒎 𝑭𝒍𝒖𝒐𝒓𝒐𝒑𝒚𝒓𝒊𝒎𝒊𝒅𝒊𝒏𝒆𝒔 𝒊𝒏 𝒕𝒉𝒆 𝑰𝒏𝒅𝒊𝒂𝒏 𝑷𝒐𝒑𝒖𝒍𝒂𝒕𝒊𝒐𝒏.

Leading the conversation is Dr. Vimal Scott Kapoor, a quadruple board-certified physician and Clinical Assistant Professor at the University of Toronto.

He is also the brother of the late Dr. Anil Kapoor, he is a Full-time Professor of Surgery (Urology) at McMaster University and a world-renowned urologist, renal transplant surgeon, and uro-oncologist. One of the most published and distinguished urologists in Canada, Dr. Anil Kapoor was a key opinion leader and sought-after speaker around the world, including at ASCO. Among his peers, he was known as a rare, naturally gifted surgeon who performed a number of pioneering surgeries in Canada.

This is a conversation about science, legacy, and what we owe the next patient.

If you work in oncology & related diagnostics, this is the webinar you don’t want to miss. Reserve your spot today. 👇

🔗 Register here: https://zoom.us/meeting/register/RIvoiFlmRpCSVsmXO5Wwig
📅 October 27 | 7:30 PM IST / 10:00 AM EDT

The era of targeted KRAS therapies is here. 🧬With breakthroughs in treating Colorectal (CRC) and Non-Small Cell Lung Can...
05/10/2026

The era of targeted KRAS therapies is here. 🧬

With breakthroughs in treating Colorectal (CRC) and Non-Small Cell Lung Cancers (NSCLC), accurate molecular profiling is no longer optional—it is critical.

The NeoDx KRAS Mutation Real-Time PCR Detection Kit empowers pathology labs to detect 7 specific somatic mutations (including G12C and G12D) with absolute confidence. Validated against WHO international standards, our assay delivers highly reliable results from both FFPE tissue and liquid biopsy samples.

Standardize your oncology screening today.
🔗 Visit: https://www.neodx.in/kras-mutation-rt-pcr-kit or DM us to connect with a technical expert.

On Gandhi Jayanti, we remember the values that continue to shape a better society truth, kindness, peace, and compassion...
02/10/2026

On Gandhi Jayanti, we remember the values that continue to shape a better society truth, kindness, peace, and compassion.

Happy Gandhi Jayanti!

In Chronic Myeloid Leukemia (CML), achieving remission marks a critical transition point: from response induction to the...
28/09/2026

In Chronic Myeloid Leukemia (CML), achieving remission marks a critical transition point: from response induction to the sustained maintenance of Deep Molecular Response (DMR).

The earliest indicator of impending relapse is a measurable logarithmic rise in BCR-ABL1 transcript copy number. Long before a TKI-resistant mutant clone achieves dominance, transcript dynamics encode the trajectory of leukemic re-expansion.

Achieving MR4.5 (≤0.0032% IS) is not merely a clinical milestone; it represents a measurable reduction in leukemic stem cell burden. Sustained DMR at this threshold significantly attenuates the probability of acquiring secondary TKI-resistance mutations (Frontiers in Oncology, 2019).

A loss of DMR or an accelerating transcript doubling time triggers an immediate therapeutic re-evaluation. Resolving this sub-clonal evolution requires quantifying Major, Minor, and Micro BCR-ABL1 transcripts with ultra-sensitive, IS-calibrated qRT-PCR ensuring early detection

IS-calibrated quantitative RT-PCR remains the gold-standard modality for proactive disease monitoring and data-driven therapeutic optimization.

Targeted tyrosine kinase inhibitor (TKI) therapy transformed chronic myeloid leukemia (CML) from a fatal hematological m...
07/09/2026

Targeted tyrosine kinase inhibitor (TKI) therapy transformed chronic myeloid leukemia (CML) from a fatal hematological malignancy into a manageable chronic condition.

This clinical paradigm shift relies on a single molecular driver: the reciprocal translocation t(9;22)(q34.1;q11.2). This event fuses BCR to ABL1, generating a constitutively active tyrosine kinase.

Targeting the kinase alters disease trajectory; quantifying transcript depletion dictates clinical management.

Once TKI therapy commences, clinical focus shifts from diagnostic identification to minimal residual disease (MRD) quantification. Quantitative RT-qPCR measures BCR-ABL1 transcript depletion against standardized reference controls, reported as log reductions on the International Scale (%IS).

Throughout September, we unpack the molecular mechanics of hematological diagnostics: transcript variant detection, %IS standardization, reference gene normalization, and MRD kinetics.

The clock starts ticking the moment a patient presents with severe respiratory symptoms. ⏱️🦠Clinicians have a narrow 48-...
02/09/2026

The clock starts ticking the moment a patient presents with severe respiratory symptoms. ⏱️🦠

Clinicians have a narrow 48-hour window to deploy effective antiviral therapies. But to treat aggressively, they need to know exactly what they are fighting. Generic "flu" screening is no longer enough when subtypes like H3N2 carry significantly higher clinical risks and mortality rates.

Running sequential tests wastes precious time and drains laboratory resources.
The NeoDx InFluDx Real-Time PCR Detection Kit is built for this exact clinical reality. Our single-tube multiplex assay provides comprehensive profiling screening for influenza A/B and differentiating H1N1 and H3N2 in under 60 minutes. By targeting highly conserved viral genes and including a beta-actin internal control, we ensure the analytical specificity needed for rapid, life-saving clinical decisions.

Stop waiting for sequential results. Standardize your respiratory panel today.

🔗 Review the full technical insert at https://www.neodx.in/respiratory-flu-panel-real-time-pcr-kit.

How well do you know your post-transplant viral complications? 🦠👇Opportunistic infections like Cytomegalovirus (CMV), Ep...
26/08/2026

How well do you know your post-transplant viral complications? 🦠👇

Opportunistic infections like Cytomegalovirus (CMV), Epstein-Barr Virus (EBV), and Human Herpesvirus 6 (HHV-6) remain significant challenges in solid organ and hematopoietic stem cell transplants.

Rapid identification and continuous monitoring are critical to preventing severe outcomes such as graft failure, pneumonitis, or Post-Transplant Lymphoproliferative Disorder (PTLD). At NeoDx, we are dedicated to advancing precise diagnostic solutions that empower clinicians to stay ahead of these viral threats.

Test your clinical immunology knowledge! Drop your matching sequence (e.g., 1-B, 2-C, 3-A) in the comments below. We’ll pin the correct answer tomorrow! 📌

Leptospirosis often presents with non-specific clinical symptoms, making laboratory confirmation essential for accurate ...
24/08/2026

Leptospirosis often presents with non-specific clinical symptoms, making laboratory confirmation essential for accurate diagnosis.

The NeoDx Leptospira Real-Time PCR Detection Kit is a multiplex TaqMan probe-based qualitative assay designed for the detection of Leptospira species by targeting the 16S rRNA region, while incorporating an Internal Control to support assay reliability. It is validated for whole blood, plasma, serum, and CSF samples and is compatible with major Real-Time PCR platforms supporting FAM and Texas Red detection channels.

Reliable molecular diagnostics begin with thoughtful assay design.
📩 Connect or visit us: https://www.neodx.in/leptospira-real-time-pcr-detection-kit

One Bite. Multiple Suspects. 🦟💥Did you know the deadliest creature on Earth is the tiny mosquito?Every August 20, World ...
20/08/2026

One Bite. Multiple Suspects. 🦟💥
Did you know the deadliest creature on Earth is the tiny mosquito?
Every August 20, World Mosquito Day marks a historic breakthrough. In 1897, British doctor Sir Ronald Ross discovered that mosquitoes transmit malaria. This monumental finding transformed public health and earned him the Nobel Prize in 1902. 🏅

Today, a single bite brings a web of dangerous, overlapping threats:
Dengue 🌡️
Malaria 🩺
West Nile Virus 🧠
Chikungunya 🦴
Zika Virus 🤰
🔬 The Power of Multiplex RT-PCR Detection

Because symptoms for these tropical fevers overlap, clinical guessing isn't an option. Mapping the precise molecular profile with NeoDx Real-Time PCR Kits allows labs to:
Differentiate between multiple pathogens in a single, high-throughput assay.
Deliver rapid diagnosis to ensure timely and effective patient treatment.

Eliminate guesswork with highly sensitive and specific target detection.
Advanced molecular diagnostic tools keep us steps ahead of vector-borne threats. 🌐 Learn more at https://www.neodx.in/infectious-diseases-pcr-kits

Celebrating the freedom that drives us forward.Happy Independence Day to everyone from all of us at NeoDx!
15/08/2026

Celebrating the freedom that drives us forward.

Happy Independence Day to everyone from all of us at NeoDx!

Address

4th Floor, Pragathi Plaza, Hebbagodi
Bangalore
560100

Opening Hours

Monday 10am - 6:30pm
Tuesday 10am - 6:30pm
Wednesday 10am - 6:30pm
Thursday 10am - 6:30pm
Friday 10am - 6:30pm

Telephone

+918123499429

Alerts

Be the first to know and let us send you an email when NeoDx posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to NeoDx:

Shortcuts

Share